FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2048156762> ?p ?o ?g. }

• W2048156762 endingPage "1052" @default.
• W2048156762 startingPage "1044" @default.
• W2048156762 abstract "Angiotensin II (Ang II) type 1 (AT₁) receptor blockers (ARBs) induce multiple pharmacological beneficial effects, but not all ARBs have the same effects and the molecular mechanisms underlying their actions are not certain. In this study, irbesartan and losartan were examined because of their different molecular structures (irbesartan has a cyclopentyl group whereas losartan has a chloride group). We analyzed the binding affinity and production of inositol phosphate (IP), monocyte chemoattractant protein-1 (MCP-1) and adiponectin. Compared with losartan, irbesartan showed a significantly higher binding affinity and slower dissociation rate from the AT₁ receptor and a significantly higher degree of inverse agonism and insurmountability toward IP production. These effects of irbesartan were not seen with the AT₁-Y113A mutant receptor. On the basis of the molecular modeling of the ARBs-AT₁ receptor complex and a mutagenesis study, the phenyl group at Tyr(113) in the AT₁ receptor and the cyclopentyl group of irbesartan may form a hydrophobic interaction that is stronger than the losartan-AT₁ receptor interaction. Interestingly, irbesartan inhibited MCP-1 production more strongly than losartan. This effect was mediated by the inhibition of nuclear factor-kappa B activation that was independent of the AT₁ receptor in the human coronary endothelial cells. In addition, irbesartan, but not losartan, induced significant adiponectin production that was mediated by peroxisome proliferator-activated receptor-γ activation in 3T3-L1 adipocytes, and this effect was not mediated by the AT₁ receptor. In conclusion, irbesartan induced greater beneficial effects than losartan due to small differences between their molecular structures, and these differential effects were both dependent on and independent of the AT₁ receptor." @default.
• W2048156762 created "2016-06-24" @default.
• W2048156762 creator A5010190969 @default.
• W2048156762 creator A5011980108 @default.
• W2048156762 creator A5013271169 @default.
• W2048156762 creator A5013948944 @default.
• W2048156762 creator A5022482534 @default.
• W2048156762 creator A5062121150 @default.
• W2048156762 creator A5084797634 @default.
• W2048156762 date "2010-07-29" @default.
• W2048156762 modified "2023-10-09" @default.
• W2048156762 title "A small difference in the molecular structure of angiotensin II receptor blockers induces AT1 receptor-dependent and -independent beneficial effects" @default.
• W2048156762 cites W1480141326 @default.
• W2048156762 cites W1592720347 @default.
• W2048156762 cites W1963735212 @default.
• W2048156762 cites W1969331222 @default.
• W2048156762 cites W1978387124 @default.
• W2048156762 cites W1980374511 @default.
• W2048156762 cites W1988334706 @default.
• W2048156762 cites W1989318421 @default.
• W2048156762 cites W1999781225 @default.
• W2048156762 cites W2000987100 @default.
• W2048156762 cites W2016400963 @default.
• W2048156762 cites W2028330435 @default.
• W2048156762 cites W2033749858 @default.
• W2048156762 cites W2045208022 @default.
• W2048156762 cites W2048748448 @default.
• W2048156762 cites W2055539224 @default.
• W2048156762 cites W2063844010 @default.
• W2048156762 cites W2083073587 @default.
• W2048156762 cites W2089722923 @default.
• W2048156762 cites W2091216428 @default.
• W2048156762 cites W2093094352 @default.
• W2048156762 cites W2100278284 @default.
• W2048156762 cites W2129508497 @default.
• W2048156762 cites W2129697991 @default.
• W2048156762 cites W2132193621 @default.
• W2048156762 cites W2133293277 @default.
• W2048156762 cites W2137588110 @default.
• W2048156762 cites W2151740641 @default.
• W2048156762 cites W2153785468 @default.
• W2048156762 cites W2155777324 @default.
• W2048156762 cites W2164310769 @default.
• W2048156762 cites W2168033876 @default.
• W2048156762 cites W2174415873 @default.
• W2048156762 cites W2279919674 @default.
• W2048156762 cites W2950302061 @default.
• W2048156762 doi "https://doi.org/10.1038/hr.2010.135" @default.
• W2048156762 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3891520" @default.
• W2048156762 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20668453" @default.
• W2048156762 hasPublicationYear "2010" @default.
• W2048156762 type Work @default.
• W2048156762 sameAs 2048156762 @default.
• W2048156762 citedByCount "42" @default.
• W2048156762 countsByYear W20481567622012 @default.
• W2048156762 countsByYear W20481567622013 @default.
• W2048156762 countsByYear W20481567622014 @default.
• W2048156762 countsByYear W20481567622015 @default.
• W2048156762 countsByYear W20481567622016 @default.
• W2048156762 countsByYear W20481567622017 @default.
• W2048156762 countsByYear W20481567622018 @default.
• W2048156762 countsByYear W20481567622021 @default.
• W2048156762 countsByYear W20481567622022 @default.
• W2048156762 countsByYear W20481567622023 @default.
• W2048156762 crossrefType "journal-article" @default.
• W2048156762 hasAuthorship W2048156762A5010190969 @default.
• W2048156762 hasAuthorship W2048156762A5011980108 @default.
• W2048156762 hasAuthorship W2048156762A5013271169 @default.
• W2048156762 hasAuthorship W2048156762A5013948944 @default.
• W2048156762 hasAuthorship W2048156762A5022482534 @default.
• W2048156762 hasAuthorship W2048156762A5062121150 @default.
• W2048156762 hasAuthorship W2048156762A5084797634 @default.
• W2048156762 hasBestOaLocation W20481567621 @default.
• W2048156762 hasConcept C123915805 @default.
• W2048156762 hasConcept C126322002 @default.
• W2048156762 hasConcept C134018914 @default.
• W2048156762 hasConcept C170493617 @default.
• W2048156762 hasConcept C185592680 @default.
• W2048156762 hasConcept C2780259554 @default.
• W2048156762 hasConcept C2780288358 @default.
• W2048156762 hasConcept C2908929049 @default.
• W2048156762 hasConcept C55493867 @default.
• W2048156762 hasConcept C71924100 @default.
• W2048156762 hasConcept C84393581 @default.
• W2048156762 hasConcept C98274493 @default.
• W2048156762 hasConceptScore W2048156762C123915805 @default.
• W2048156762 hasConceptScore W2048156762C126322002 @default.
• W2048156762 hasConceptScore W2048156762C134018914 @default.
• W2048156762 hasConceptScore W2048156762C170493617 @default.
• W2048156762 hasConceptScore W2048156762C185592680 @default.
• W2048156762 hasConceptScore W2048156762C2780259554 @default.
• W2048156762 hasConceptScore W2048156762C2780288358 @default.
• W2048156762 hasConceptScore W2048156762C2908929049 @default.
• W2048156762 hasConceptScore W2048156762C55493867 @default.
• W2048156762 hasConceptScore W2048156762C71924100 @default.
• W2048156762 hasConceptScore W2048156762C84393581 @default.
• W2048156762 hasConceptScore W2048156762C98274493 @default.
• W2048156762 hasIssue "10" @default.

• next